These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 14555767

  • 1. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
    Zhang YW, Su Y, Volpert OV, Vande Woude GF.
    Proc Natl Acad Sci U S A; 2003 Oct 28; 100(22):12718-23. PubMed ID: 14555767
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 3. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C.
    Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
    Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z.
    Cancer Res; 2005 Aug 15; 65(16):7071-80. PubMed ID: 16103054
    [Abstract] [Full Text] [Related]

  • 6. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 15; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 7. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
    Naim R, Tolnay E, Mueller KM, Kuhnen C.
    Int J Mol Med; 2004 Nov 15; 14(5):787-91. PubMed ID: 15492846
    [Abstract] [Full Text] [Related]

  • 8. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.
    Zhang YW, Wang LM, Jove R, Vande Woude GF.
    Oncogene; 2002 Jan 10; 21(2):217-26. PubMed ID: 11803465
    [Abstract] [Full Text] [Related]

  • 9. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, Rosen EM.
    Lab Invest; 1997 Mar 10; 76(3):339-53. PubMed ID: 9121117
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE.
    Clin Cancer Res; 1999 Nov 15; 5(11):3695-703. PubMed ID: 10589789
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells.
    Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S.
    Biochem Biophys Res Commun; 1998 Aug 10; 249(1):73-7. PubMed ID: 9705834
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
    Sengupta S, Gherardi E, Sellers LA, Wood JM, Sasisekharan R, Fan TP.
    Arterioscler Thromb Vasc Biol; 2003 Jan 01; 23(1):69-75. PubMed ID: 12524227
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 20. Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells.
    Ronen D, Altstock RT, Firon M, Mittelman L, Sobe T, Resau JH, Vande Woude GF, Tsarfaty I.
    Cell Growth Differ; 1999 Feb 15; 10(2):131-40. PubMed ID: 10074906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.